Identification of SLC45A4 as a pain gene encoding a neuronal polyamine transporter.
Steven J. MiddletoniD, Sigurbjörn MarkússoniD, Mikael Åkerlund, Justin C. DemeiD, Mandy TsengiD, Wenqianglong LiiD, Sana R. ZuberiiD, Gabriel Kuteyi, Peter SarkiesiD, Georgios BaskozosiD, Jimena Pérez-SáncheziD, Harry L. HébertiD, Sylvanus ToikumoiD, Adham FarahiD, Susan MaxwelliD, Yin Yao DongiD, Henry R. KranzleriD, John E. LinleyiD, Blair Hamilton SmithiD, Susan M. LeaiD, Joanne L. ParkeriD, Valeriya LyssenkoiD, Simon L. NewsteadiD, David BennettiD
Abstract
Polyamines are regulatory metabolites with key roles in transcription, translation, cell signalling and autophagy1. They are implicated in multiple neurological disorders including stroke, epilepsy and neurodegeneration and can regulate neuronal excitability through interactions with ion channels2. Polyamines have been linked to pain showing altered levels in human persistent pain states and modulation of pain behaviour in animal models3. However, the systems governing polyamine transport within the nervous system remain unclear. In undertaking a Genome Wide Association Study (GWAS) of chronic pain intensity in the UK-Biobank we found significant association with variants mapping to the SLC45A4 gene locus. In the mouse nervous system SLC45A4 expression is enriched in all sensory neuron sub-types within the dorsal root ganglion including nociceptors. Cell-based assays show that SLC45A4 is a selective plasma membrane polyamine transporter, whilst the cryo-EM structure reveals a novel regulatory domain and basis for polyamine recognition. Mice lacking SLC45A4 show normal mechanosensitivity but reduced sensitivity to noxious heat and algogen induced tonic pain that is associated with reduced excitability of peptidergic nociceptors. Our findings thus establish a role for neuronal polyamine transport in pain perception and identify a new target for therapeutic intervention in pain treatment.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Chemogenetic silencing of NaV1.8 positive sensory neurons reverses chronic neuropathic and bone cancer pain in FLEx PSAM4-GlyR mice
Rayan Haroun, Samuel J. Gossage, … John N. Wood·eNeuroPeer-reviewed·Sep 1, 2023
- Analgesic targets identified in mouse sensory neuron somata and terminal pain translatomes
Muhammad Ali Bangash, Cankut Çubuk, … Jing Zhao·Cell ReportsPeer-reviewed·Aug 1, 2024
- Nociceptors use multiple neurotransmitters to drive pain
Donald Iain MacDonald, Rakshita Balaji, Alexander Theodore Chesler·bioRxiv·Sep 9, 2025
- Molecular signatures of maladaptive plasticity in the amygdala in a rat model of chronic neuropathic pain
Peyton Presto, Julian Cardenas, … Igor Ponomarev·CellsPeer-reviewed·Apr 25, 2026
- NaV1.7-dependent peripheral sensitization drives chronic pain in Parkinson's disease
Tyler S. Nelson, Naomi K Grabus, … Rajesh Khanna·bioRxiv·Sep 15, 2026
- Inhibition of sensory neuron driven acute, inflammatory, and neuropathic pain using a humanised chemogenetic system
Jimena Pérez-Sánchez, Steven J. Middleton, … David Bennett·bioRxiv·Mar 21, 2023